MiR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer

American Journal of Pathology

Volumn 180, Issue 5, 2012, Pages 1808-1815

  Puerta Gil, Patricia ^a   Garca Baquero, Rodrigo ^b   Jia, Angela Y ^c   Ocaa, Sara ^d   Alvarez Mgica, Miguel ^e   Alvarez Ossorio, Jose L ^b   Cordon Cardo, Carlos ^c   Cava, Fernando ^d   Snchez Carbayo, Marta ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^c NewYork Presbyterian Hospital   (United States)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; MICRORNA; MICRORNA 143; MICRORNA 222; MICRORNA 452; PROTEIN BCL 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; DIAGNOSTIC ACCURACY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; MALE; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA EXTRACTION; TUMOR BIOPSY; TUMOR CLASSIFICATION; TUMOR VOLUME; URINALYSIS; VIRUS ONCOGENE;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84860251052     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.01.034     Document Type: Article

References (30)

1. F. Gottardo, C.G. Liu, M. Ferracin, G.A. Calin, M. Fassan, P. Bassi, C. Sevignani, D. Byrne, M. Negrini, F. Pagano, L.G. Gomella, C.M. Croce, R. Baffa Micro-RNA profiling in kidney and bladder cancers Urol Oncol 25 2007 387 392
2. H. Yang, C.P. Dinney, Y. Ye, Y. Zhu, H.B. Grossman, X. Wu Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer Cancer Res 68 2008 2530 2537
3. L.A. Neely, K.M. Rieger-Christ, B.S. Neto, A. Eroshkin, J. Garver, S. Patel, N.A. Phung, S. McLaughlin, J.A. Libertino, D. Whitney, I.C. Summerhayes A microRNA expression ratio defining the invasive phenotype in bladder tumors Urol Oncol 28 2010 39 48
4. S. Veerla, D. Lindgren, A. Kvist, A. Frigyesi, J. Staaf, H. Persson, F. Liedberg, G. Chebil, S. Gudjonsson, A. Borg, W. Mnsson, C. Rovira, M. Hglund miRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31 Int J Cancer 124 2009 2236 2242
5. T. Lin, W. Dong, J. Huang, Q. Pan, X. Fan, C. Zhang, L. Huang MicroRNA-143 as a tumor suppressor for bladder cancer J Urol 181 2009 1372 1380
6. M. Hanke, K. Hoefing, H. Merz, A.C. Feller, I. Kausch, D. Jocham, J.M. Warnecke, G. Sczakiel A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer Urol Oncol 28 2010 655 661
7. T. Ichimi, H. Enokida, Y. Okuno, R. Kunimoto, T. Chiyomaru, K. Kawamoto, K. Kawahara, K. Toki, K. Kawakami, K. Nishiyama, G. Tsujimoto, M. Nakagawa, N. Seki Identification of novel miRNA targets based on microRNA signatures in bladder cancer Int J Cancer 125 2009 345 352
8. R. Baffa, M. Fassan, S. Volinia, B. O'Hara, C.G. Liu, J.P. Palazzo, M. Gardiman, M. Rugge, L.G. Gomella, C.M. Croce, A. Rosenberg MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets J Pathol 219 2009 214 221
9. G. Wang, H. Zhang, H. He, W. Tong, B. Wang, G. Liao, Z. Chen, C. Du Up-regulation of microRNA in bladder tumor tissue is not common Int Urol Nephrol 42 2010 95 102
10. L. Dyrskjøt, M.S. Ostenfeld, J.B. Bramsen, A.N. Silahtaroglu, P. Lamy, R. Ramanathan, N. Fristrup, J.L. Jensen, C.L. Andersen, K. Zieger, S. Kauppinen, B.P. Ulhøi, J. Kjems, M. Borre, T.F. Orntoft Genomic profiling of miRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro Cancer Res 69 2009 4851 4860
11. L. Adam, M. Zhong, W. Choi, W. Qi, M. Nicoloso, A. Arora, G. Calin, H. Wang, A. Siefker-Radtke, D. McConkey, M. Bar-Eli, C. Dinney miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy Clin Cancer Res 15 2009 5060 5072
12. J.F. Catto, S. Miah, H.C. Owen, H. Bryant, K. Myers, E. Dudziec, S. Larré, M. Milo, I. Rehman, D.J. Rosario, E. Di Martino, M.A. Knowles, M. Meuth, A.L. Harris, F.C. Hamdy Distinct microRNA alterations characterize high- and low-grade bladder cancer Cancer Res 69 2009 8472 8481
13. M.S. Ostenfeld, J.B. Bramsen, P. Lamy, S.B. Villadsen, N. Fristrup, K.D. Sørensen, B. Ulhøi, M. Borre, J. Kjems, L. Dyrskjøt, T.F. Orntoft miR-145 induces caspase-dependant and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumors Oncogene 29 2010 1073 1084
14. T. Chiyomaru, H. Enokida, S. Tatarano, K. Kawahara, Y. Uchida, K. Nishiyama, L. Fujimura, N. Kikkawa, N. Seki, M. Nakagawa miR-145 and miR-133a function as tumor suppressors and directly regulate FSCN1 expression in bladder cancer Br J Cancer 102 2010 883 891
15. E.D. Wiklund, J.B. Bramsen, T. Hulf, L. Dyrskjøt, R. Ramanathan, T.B. Hansen, S.B. Villadsen, S. Gao, M.S. Ostenfeld, M. Borre, M.E. Peter, T.F. Ørntoft, J. Kjems, S.J. Clark Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer Int J Cancer 128 2011 1327 1334
16. Y. Han, J. Chen, X. Zhao, C. Liang, Y. Wang, L. Sun, Z. Jiang, Z. Zhang, R. Yang, J. Chen, Z. Li, A. Tang, X. Li, J. Ye, Z. Guan, Y. Gui, Z. Cai MicroRNA expression signatures of bladder cancer revealed by deep sequencing PLoS One 6 2011 e18286
17. S. Noguchi, T. Mori, Y. Hoshino, K. Maruo, N. Yamada, Y. Kitade, T. Naoe, Y. Akao MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells Cancer Lett 307 2011 211 220
18. Z. Kirkali, T. Chan, M. Manoharan, F. Algaba, C. Busch, L. Cheng, L. Kiemeney, M. Kriegmair, R. Montironi, W.M. Murphy, I.A. Sesterhenn, M. Tachibana, J. Weider Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 66 2005 4 34
19. M. Sanchez-Carbayo, K. Schwarz, E. Charytonowicz, C. Cordon-Cardo, P. Mundel Tumor suppressor role for myopodin in bladder cancer: loss of nuclear expression of myopodin is cell-cycle dependent and predicts clinical outcome Oncogene 22 2003 5298 5305
20. J.T.G. Pena, C. Sohn-Lee, S.H. Rouhanifard, J. Ludwig, M. Hafner, A. Mihailovic, C. Lim, D. Holoch, P. Berninger, M. Zavolan, T. Tuschl miRNA in situ hybridization in mammalian tissues fixed with formaldehyde and EDC Nat Methods 6 2009 139 141
21. S. Jørgensen, A. Baker, S. Møller, B.S. Nielsen Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes Methods 52 2010 375 381
22. J.W. Catto, A. Alcaraz, A.S. Bjartell, R. De Vere White, C.P. Evans, S. Fussel, F.C. Hamdy, O. Kallioniemi, L. Mengual, T. Schlomm, T. Visakorpi MicroRNA in prostate, bladder, and kidney cancer: a systematic review Eur Urol 59 2011 671 681
23. Z.Y. Tsai, S. Singh, S.L. Yu, L.P. Kao, B.Z. Chen, B.C. Ho, P.C. Yang, S.S. Li Identification of microRNAs regulated by activin A in human embryonic stem cells J Cell Biochem 109 2010 93 102
24. W.M. Schmidt, A.O. Spiel, B. Jilma, M. Wolzt, M. Mller In vivo profile of the human leukocyte microRNA response to endotoxemia Biochem Biophys Res Commun 380 2009 437 441
25. H.C. Chen, G.H. Chen, Y.H. Chen, W.L. Liao, C.Y. Liu, K.P. Chang, Y.S. Chang, S.J. Chen MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma Br J Cancer 100 2009 1002 1011
26. W. Kassouf, P.C. Black, T. Tuziak, J. Bondaruk, S. Lee, G.A. Brown, L. Adam, C. Wei, K. Baggerly, M. Bar-Eli, D. McConkey, B. Czerniak, C.P. Dinney Distinctive expression pattern of ErbB family receptors signifies an aggressive variant of bladder cancer J Urol 179 2008 353 358
27. N.H. Chow, H.S. Liu, H.B. Yang, S.H. Chan, I.J. Su Expression patterns of ErbB receptor family in normal urothelium and transitional cell carcinoma: an immunohistochemical study Virchows Arch 430 1997 461 466
28. W.I. De Boer, A.B. Houtsmuller, V. Izadifar, B. Muscatelli-Groux, T.H. Van der Kwast, D.K. Chopin Expression and functions of EGF, FGF and TGFbeta-growth-factor family members and their receptors in invasive human transitional-cell-carcinoma cells Int J Cancer 71 1997 284 291
29. T.T. Junttila, M. Laato, T. Vahlberg, K.O. Sderstrm, T. Visakorpi, J. Isola, K. Elenius Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients Clin Cancer Res 9 2003 5346 5357
30. T. Rajkumar, G.W. Stamp, H.S. Pandha, J. Waxman, W.J. Gullick Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer J Pathol 179 1996 381 385